Literature DB >> 3500769

Epidemiology of primary intracranial neoplasms in Manitoba, Canada.

G R Sutherland1, R Florell, D Louw, N W Choi, A A Sima.   

Abstract

The incidence of primary intracranial tumors in Manitoba, Canada was reviewed. From 1980 through 1985, 657 tumors were diagnosed. The crude incidence rates were 10.2/100,000 for males and 10.8/100,000 for females. The three most common tumors were: astrocytoma 281 (43%), meningioma 145 (22%), and pituitary adenoma 111 (17%). Average annual incidence rates for all tumors showed a bimodal distribution with one peak in the 0-4 age group (4.2/100,000), and the other in the 60-69 age group (27.2/100,000). For malignant astrocytoma, the age-specific annual incidence rate increased to the seventh decade where it reached a peak of 14.3/100,000. The incidence of benign astrocytoma remained relatively constant with age at 1.1/100,000. The annual incidence of meningioma increased with age up to the eighth decade reaching 7.2/100,000. Of the 145 meningiomas, 56 (39%) were meningotheliomatous, 48 (33%) transitional, 10 (7%) malignant, 7 (5%) fibroblastic, 6 (4%) psammomatous, 3 (2%) angioblastic, and 15 (10%) lacked pathologic diagnosis. The annual incidence of pituitary adenoma showed two peaks, the first occurring in the third decade (2.6/100,000) and the second in the eighth decade (3.2/100,000). Although the incidence of meningioma was relatively high, the clinical features and pathologic patterns of these tumors were not unlike those previously reported in the literature.

Entities:  

Mesh:

Year:  1987        PMID: 3500769

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  14 in total

1.  Demographic profile of patients diagnosed with intracranial meningiomas in two academic hospitals in Johannesburg, South Africa: a 12-month prospective study.

Authors:  Kaunda Ibebuike; John Ouma
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging.

Authors:  Boguslaw Tomanek; Umar Iqbal; Barbara Blasiak; Abedelnasser Abulrob; Homam Albaghdadi; John R Matyas; Dragana Ponjevic; Garnette R Sutherland
Journal:  Neuro Oncol       Date:  2011-10-19       Impact factor: 12.300

3.  Incidence of vestibular schwannomas in the United States.

Authors:  Varun R Kshettry; Jason K Hsieh; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

4.  Major intratumoral hemorrhage of a petroclival atypical meningioma: case report and review of literature.

Authors:  Erwin Zeta Mangubat; Richard W Byrne
Journal:  Skull Base       Date:  2010-11

5.  High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma.

Authors:  P A Forsyth; T D Laing; A W Gibson; N B Rewcastle; P Brasher; G Sutherland; R N Johnston; D R Edwards
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

Review 6.  Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results.

Authors:  C E Counsell; R Grant
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

7.  Osseous metastasis of pineoblastoma: a case report and review of the literature.

Authors:  Claire Constantine; Douglas C Miller; Sharon Gardner; Casilda Balmaceda; Jonathan Finlay
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

Review 8.  Epidemiology and etiology of intracranial meningiomas: a review.

Authors:  M Bondy; B L Ligon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

Review 9.  Current status and future opportunities for controlling acromegaly.

Authors:  Shlomo Melmed; Mary Lee Vance; Ariel L Barkan; Bengt-Ake Bengtsson; David Kleinberg; Anne Klibanski; Peter J Trainer
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

10.  Age-related differences in 1p and 19q deletions in oligodendrogliomas.

Authors:  Yvonne Myal; Marc R Del Bigio; Roy H Rhodes
Journal:  BMC Clin Pathol       Date:  2003-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.